학술논문
Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial
Document Type
Article
Author
Sapoval, M.; Déan, C.; Thiounn, N.; Descazeaud, A.; Ruffion, A.; Pagnoux, G.; Duarte, R.C.; Robert, G.; Petitpierre, F.; Karsenty, G.; Vidal, V.; Murez, T.; Vernhet-Kovacsik, H.; de la Taille, A.; Kobeiter, H.; Mathieu, R.; Heautot, J.-F.; Droupy, S.; Frandon, J.; Barry Delongchamps, N.; Korb-Savoldelli, V.; Durand-Zaleski, I.; Pereira, H.; Chatellier, G.; Pellerin, O.; Sabatier, B.; Dariane, C.; Gabay, B.; Moldovan, P.C.; Rouvière, O.; Champagnac, J.; Lagabrielle, S.; Grenier, N.; Boissier, R.; Lechevallier, É.; Izaaryene, J.-J.; Tradi, F.; Arrouasse, R.; Defontaines, J.; Joseph, X.; Le Corvoisier, P.; Sbidian, E.; Champy, C.; Chiaradia, M.; Chevrot, A.; Blion, C.; Goupil, J.; Bulsei, J.; Vappereau, A.
Source
In: The Lancet Regional Health - Europe . (The Lancet Regional Health - Europe, August 2023, 31)
Subject
Language
English
ISSN
26667762